Ro Acquires Modern Fertility for Over $225 Million

Ro Acquires Modern Fertility in a Significant Healthcare Deal

Ro, a prominent digital healthcare company specializing in elective care and telemedicine, recently announced its acquisition of Modern Fertility, a reproductive health company established in 2017. Valued at $5 billion, Ro reportedly secured Modern Fertility for approximately $225 million in a deal primarily structured with stock, as estimated by Axios, though TechCrunch sources indicate the final figure exceeded this amount.

Expanding Beyond Initial Focus

Founded in 2017, Ro has strategically broadened its scope beyond its original focus on solutions for men experiencing erectile dysfunction. The company now provides services encompassing women’s health, smoking cessation programs, and treatments for over 20 different conditions.

These include areas like sexual wellness, weight management, and allergy relief. This acquisition is anticipated to seamlessly integrate with Rory, Ro’s dedicated women’s healthcare division, which emphasizes convenient online consultations, discreet delivery, and streamlined healthcare access.

Fertility Services Integration and Growth

The integration of Modern Fertility will introduce fertility testing and comprehensive reproductive health services to Ro’s existing women’s health offerings. Both Ro and Modern Fertility experienced substantial revenue growth, with each reporting a 300% increase in revenue last year and in Q1 2021 respectively.

Afton Vechery and Carly Leahy, the co-founders of Modern Fertility, are slated to lead this expanded vertical within Ro.

The Rise of Direct-Pay Healthcare

This acquisition represents a noteworthy development in the evolving healthcare landscape, particularly concerning the growing trend of “cash-pay, no insurance” models. Ro has consistently championed the idea that healthcare can be successfully delivered through direct consumer payments, bypassing traditional insurance complexities.

While this approach excludes individuals with existing insurance coverage – a significant portion of the American population – it caters to those seeking convenient and accessible healthcare options.

Strategic Consolidation and Consumer Convenience

By incorporating Modern Fertility, Ro aims to enhance its appeal to consumers by offering a centralized platform for various healthcare needs. The convenience of accessing multiple services, potentially beginning with fertility solutions, is expected to foster greater customer loyalty.

Companies like Everlywell and Future Family have already demonstrated the market demand for comprehensive fertility solutions.

Synergy with Previous Acquisition

This deal aligns strategically with Ro’s December 2020 acquisition of Workpath, an in-home care API. Workpath enables Ro to establish a fully integrated primary care platform, facilitating in-home professional visits and diagnostic testing.

Future Outlook and M&A Activity

Ro’s acquisition strategy has shifted from broad service expansion in the previous year to a more focused approach, identifying specific healthcare services with high consumer demand. Having secured nearly $900 million in venture capital funding, further mergers and acquisitions are anticipated as the year progresses.

The company is actively positioning itself to capitalize on emerging trends and solidify its presence in the rapidly evolving digital healthcare market.